Clearstead Advisors, LLC

Position in VIR — Vir Biotechnology, Inc.

CIK 842775 CLEVELAND, OH

Position in VIR

as of Mar 31, 2026 · filed May 6, 2026 Compact

Position Value

$10,898,944

+$10,896,815 QoQ

Shares Held

1,216,400

+326012.6% QoQ

Ownership

0.721%

of shares outstanding

% of Portfolio

0.24%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

12 quarters on record

Voting authority Sole 7.86879316014469.ToString("F0")% Shared 0.ToString("F0")% None 92.13120683985531.ToString("F0")%

Healthcare · as of Mar 31, 2026

Clearstead Advisors, LLC holds $49,362,840 across 76 Biotechnology names. VIR ranks #2 (22.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DNLI	Denali Therapeutics Inc.	737,990	$14,169,408
2	VIR	Vir Biotechnology, Inc. This page	1,216,400	$10,898,944
3	NAUT	Nautilus Biotechnology, Inc.	2,329,784	$9,039,561
4	BEAM	Beam Therapeutics Inc.	121,230	$2,888,910
5	IBRX	ImmunityBio, Inc.	345,700	$2,651,519
6	VRTX	Vertex Pharmaceuticals Inc / Ma	3,427	$1,530,292
7	SRRK	Scholar Rock Holding Corp	26,074	$1,281,797
8	SANA	Sana Biotechnology, Inc.	336,781	$969,929

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,898,944	1,216,400	+326012.6%	Shares	Sole	2026-05-06
2025-09-30	$2,129	373	+997.1%	Shares	Sole	2025-11-10
2025-06-30	$171	34	+70.0%	Shares	Sole	2025-08-08
2023-06-30	$490	20	0.0%	Shares	Sole	2023-08-07
2023-03-31	$465	20	0.0%	Shares	Sole	2023-05-09
2022-12-31	$506	20	0.0%	Shares	Sole	2023-02-14
2022-09-30	$385	20	0.0%	Shares	Sole	2022-11-15
2022-06-30	$509	20	0.0%	Shares	Sole	2022-08-12
2022-03-31	$514	20	0.0%	Shares	Sole	2022-05-04
2021-12-31	$837	20	+100.0%	Shares	Sole	2022-02-14
2021-09-30	$435	10	0.0%	Shares	Sole	2021-11-12
2021-06-30	$472	10	—	Shares	Sole	2021-08-12
No filing history on record for this holder in this stock.